Complex PCI in high bleeding risk patients, the way forward!

Sponsored by Terumo

Discussants: A. Al Nooryani, W. Alkashkari

Spokesperson: R. Al-Bawardy

Summary

Consult this session for insights on customizing PCI strategies for high-bleeding-risk patients, and selecting Drug-Eluting Stents in complex PCI. Additionally, examine the outcomes of the Ultimaster DES in high-bleeding-risk trials, particularly in the context of short Dual Antiplatelet Therapy.

Learning Objectives

To tailor PCI strategies in high bleeding risk patients
To reflect about DES selection in complex PCI for high bleeding risk patients
To review Ultimaster DES results with short DAPT in high bleeding risk trial